The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: The prospective epidemiological study of myocardial infarction (PRIME study)

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 399-405

  Luc, Gérald ^a,b   Bard, Jean Marie ^a,b   Evans, Alun ^c   Arveiler, Dominique ^d   Ruidavets, Jean Bernard ^e   Amouyel, Philippe ^a   Ducimetiere, Pierre ^f  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d AIMT Bas Rhin   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f HÔPITAL BROUSSAIS   (France)

Author keywords

Apolipoprotein AI; Environmental factors; LpAI; Prospective study

Indexed keywords

APOLIPOPROTEIN A1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; FRANCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED KINGDOM;

ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; BODY CONSTITUTION; CHOLESTEROL; EXERCISE; FRANCE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTHERN IRELAND; PROSPECTIVE STUDIES; SMOKING; TRIGLYCERIDES;

EID: 0033811991     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00484-0     Document Type: Article

References (43)

1. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjorland M.C., Hulley S.B., Kagan A., Zukel W.J. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 55:1977;767.
2. Nikkilä E.A. Serum high-density lipoprotein and coronary heart disease. Lancet. 2:1976;320.
3. Miller G.J., Miller N.E. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet. 1:1975;16.
4. Vergani C., Trovato G., Delu A., Pietrogrande M., Dioguardi N. Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease. J. Clin. Pathol. 31:1978;772.
5. Riesen W.F., Mordasini R., Salzmann C., Theler A., Gurtner H.P. Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis. 37:1980;157.
6. Assmann G., Schmitz G., Brewer H.B. The Metabolic Basis of Inherited Disease. 1989;1267-1282 McGraw-Hill, New York.
7. Von Eckardstein A., Huang Y., Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5:1994;404.
8. Xu S.Z., Laccotripe M., Huang X.W., Rigotti A., Zannis V.I., Krieger M. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38:1997;1289.
9. Leroy A., Dallongeville J., Fruchart J.C. Apolipoprotein A-I-containing lipoproteins and atherosclerosis. Curr. Opin. Lipidol. 6:1995;281.
10. Alaupovic P. The Physicochemical Immunological Heterogeneity of Plasma High Density Lipoproteins. 1984;1-45 Elsevier, Amsterdam.
11. Cheung M.C., Albers J.J. Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios. J. Lipid Res. 20:1979;200.
12. Nestruck A.C., Niedmann P.D., Wieland H., Seidel D. Chromatofocusing of human high density lipoproteins and isolation of lipoproteins A and A-I. Biochim. Biophys. Acta. 753:1983;65.
13. Atmeh R.F., Shepherd J., Packard C.J. Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. Biochim. Biophys. Acta. 751:1983;175.
14. Cheung M.C., Albers J.J. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259:1984;12201.
15. Ohta T., Hattori S., Nishiyama S., Matsuda I. Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females. J. Lipid Res. 29:1988;721.
16. Cheung M.C., Albers J.J. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J. Lipid Res. 23:1982;747.
17. Barbaras R., Puchois P., Fruchart J.C., Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Biochem. Biophys. Res. Commun. 142:1987;63.
18. Parra H.J., Arveiler D., Evans A.E., Cambou J.P., Amouyel P., Bingham A., McMaster D., Schaffer P., Douste Blazy P., Luc G., Ducimetière P., Fruchart J.-C., Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler. Thromb. 12:1992;701.
19. Steinmetz J., Boerwinkle E., Gueguen R., Visvikis S., Henny J., Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 92:1992;219.
20. Steinmetz J., Choukaife A., Visvikis S., Henny J., Siest G. Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits. Clin. Chem. 36:1990;677.
21. Puchois P., Ghalim N., Zylberberg G., Fievet P., Demarquilly C., Fruchart J.C. Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions. Arch. Intern. Med. 150:1990;1638.
22. Valimaki M., Laitinen K., Ylikahri R., Ehnholm C., Jauhiainen M., Bard J.M., Fruchart J.C., Taskinen M.R. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism. 40:1991;1168.
23. Richard F., Marecaux N., Dallongeville J., Devienne M., Tiem N., Fruchart J.C., Fantino M., Zylberberg G., Amouyel P. Effect of smoking cessation on lipoprotein A-I and lipoprotein A- I:A-II levels. Metabolism. 46:1997;711.
24. The PRIME study: classical risk factors do not explain the several-fold differences in risk of coronary heart disease between France and Northern Ireland. Q. J. Med. 91:1998;667.
25. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 36:1982;936.
26. Haarbo J., Hassager C., Schlemmer A., Christiansen C. Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women. Atherosclerosis. 84:1990;239.
27. Haffner S.M., Applebaum Bowden D., Wahl P.W., Hoover J.J., Warnick G.R., Albers J.J., Hazzard W.R. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis. 5:1985;169.
28. Freedman D.S., Jacobsen S.J., Barboriak J.J., Sobocinski K.A., Anderson A.J., Kissebah A.H., Sasse E.A., Gruchow H.W. Body fat distribution and male/female differences in lipids and lipoproteins [see comments]. Circulation. 81:1990;1498.
29. Assmann G., Funke H., Schriewer H. The relationship of HDL-apolipoprotein A-I and HDL-cholesterol to risk factors of coronary heart disease: initial results of the prospective epidemiological study in company employees in Westfalia. J. Clin. Chem. Clin. Biochem. 20:1982;287.
30. Lecerf J.M., Masson A., Fruchart J.C., Bard J.M. Serum LpA-I lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects. Diabetes Metab. 22:1996;331.
31. Brinton E.A., Eisenberg S., Breslow J.L. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14:1994;707.
32. 2 cholesterol level in older adults. New Engl. J. Med. 322:1990;229.
33. Sjostrom L., Kvist H. Regional body fat measurements with CT-scan and evaluation of anthropometric predictions. Acta Med. Scand. Suppl. 723:1988;169.
34. Marquesvidal P., Cambou J.P., Nicaud V., Luc G., Evans A., Arveiler D., Bingham A., Cambien F. Cardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis. 115:1995;225.
35. Phillips N.R., Havel R.J., Kane J.P. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco and beverages containing caffeine. Arteriosclerosis. 1:1981;13.
36. Gottrand F, Beghin L, Duhal N, Lacroix B, Bonte FJ, Fruchart J-C, Luc G. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein A-IId. Eur J Clin Invest 1999;29:387.
37. Lagrost L., Athias A., Herbeth B., Guyarddangremont V., Artur Y., Paille F., Gambert P., Lallemant C. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins-physiological relevance in alcoholic patients. J. Biol. Chem. 271:1996;19058.
38. Stubbe I., Eskilsson J., Nilsson E.P. High-density lipoprotein concentrations increase after stopping smoking. Br. Med. J. 284:1982;1511.
39. Zmuda J.M., Yurgalevitch S.M., Flynn M.M., Bausserman L.L., Saratelli A., Spannausmartin D.J., Herbert P.N., Thompson P.D. Exercise training has little effect on HDL levels and metabolism in men with initially low HDL cholesterol. Atherosclerosis. 137:1998;215.
40. Crouse S.F., Obrien B.C., Grandjean P.W., Lowe R.C., Rohack J.J., Green J.S., Tolson H. Training intensity, blood lipids, and apolipoproteins in men with high cholesterol. J. Appl. Physiol. 82:1997;270.
41. MacAuley D., McCrum E.E., Stott G., Evans A.E., Duly E., Trinick T., Sweeney K., Boreham C.A. Physical activity, lipids, apolipoproteins, and Lp(a) in the Northern Ireland Health and Activity Survey. Med. Sci. Sports Exerc. 28:1996;720.
42. Patsch W., Sharrett A.R., Sorlie P.D., Davis C.E., Brown S.A. The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 136:1992;546.
43. Frey I., Kamps H., Baumstark M.W., Berg A., Keul J. Distribution of lipoprotein species (LpA-I, LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men [published erratum appears in Clin Chim Acta 1993;215(1):125]. Clin. Chim. Acta. 211:1992;167.